Drug resistant White fungus: another catastrophic fungus emergence amidst COVID-19 in India.
作者信息
Ghosh Shayon, Patelia Shreya, Mehedi Hasan Mohammad, Ghosh Asmita, Jain Shubhika, Patel Tapan
机构信息
GMERS Medical College and Hospital, Gujarat, India.
Department of Biochemistry and Molecular Biology, Faculty of Life Science, Mawlana Bhashani Science and Technology University, Tangail, Bangladesh.
出版信息
Pathog Glob Health. 2021 Oct-Dec;115(7-8):435-436. doi: 10.1080/20477724.2021.1960762. Epub 2021 Jul 27.
Abstract
摘要
相似文献
1
Drug resistant White fungus: another catastrophic fungus emergence amidst COVID-19 in India.耐药白真菌：印度新冠疫情期间出现的又一种灾难性真菌。
Pathog Glob Health. 2021 Oct-Dec;115(7-8):435-436. doi: 10.1080/20477724.2021.1960762. Epub 2021 Jul 27.
2
Black fungus immunosuppressive epidemic with Covid-19 associated mucormycosis (zygomycosis): a clinical and diagnostic perspective from India.新冠疫情相关毛霉菌病（接合菌病）：来自印度的临床和诊断视角下的黑木耳免疫抑制流行。
Immunogenetics. 2022 Apr;74(2):197-206. doi: 10.1007/s00251-021-01226-5. Epub 2021 Oct 1.
3
False reassurance or inadequate drug levels?虚假的安慰还是药物水平不足？
Indian J Med Res. 2020;152(1 & 2):121-123. doi: 10.4103/ijmr.IJMR_2485_20.
4
Finding stability amidst the COVID-19 pandemic: The impact of emergency temporary housing for people who use drugs.在新冠疫情期间寻求稳定：紧急临时住房对吸毒者的影响。
Drug Alcohol Rev. 2022 Jan;41(1):7-8. doi: 10.1111/dar.13335. Epub 2021 Jun 16.
5
Covid-19 and mucormycosis (Black Fungus): An epidemic within the pandemic.Covid-19 与毛霉菌病（黑真菌）：大流行中的一场疫情。
Rocz Panstw Zakl Hig. 2021;72(3):239-244. doi: 10.32394/rpzh.2021.0169.
6
The impact of mucormycosis (black fungus) on SARS-CoV-2-infected patients: at a glance.新型冠状病毒感染患者中毛霉菌病（黑霉病）的影响：一目了然。
Environ Sci Pollut Res Int. 2022 Oct;29(46):69341-69366. doi: 10.1007/s11356-022-22204-8. Epub 2022 Aug 19.
7
Online Registry of COVID-19-Associated Mucormycosis Cases, India, 2021.2021 年印度 COVID-19 相关毛霉菌病病例在线登记册。
Emerg Infect Dis. 2021;27(11):2963-2965. doi: 10.3201/eid2711.211322. Epub 2021 Sep 29.
8
Impacts of Covid-19 & black fungus on diabetes patients in India.新冠疫情和黑真菌对印度糖尿病患者的影响。
Afr Health Sci. 2023 Sep;23(3):422-430. doi: 10.4314/ahs.v23i3.49.
9
Voices Amidst the COVID-19 Pandemic: Dispatch From India.新冠疫情中的声音：来自印度的报道
Asian J Anesthesiol. 2020 Dec 1;58(4):121-123. doi: 10.6859/aja.202012_58(4).0001. Epub 2021 Feb 4.
10
Cycle threshold values in RT-PCR to determine dynamics of SARS-CoV-2 viral load: An approach to reduce the isolation period for COVID-19 patients.实时荧光 RT-PCR 循环阈值用于确定 SARS-CoV-2 病毒载量的动态变化：一种减少 COVID-19 患者隔离期的方法。
J Med Virol. 2021 Dec;93(12):6794-6797. doi: 10.1002/jmv.27206. Epub 2021 Jul 23.
引用本文的文献
1
Antifungal Drugs Shortage in India amidst Looming Increase in Invasive Fungal Infections among COVID-19 Patients: An Impending Crisis.印度抗真菌药物短缺，新冠患者侵袭性真菌感染风险渐高：一场迫在眉睫的危机。
Innov Pharm. 2022 Dec 12;13(2). doi: 10.24926/iip.v13i2.4480. eCollection 2022.
2
Emergence of a medley of invasive fungal infections amidst the coronavirus disease 2019 (COVID-19) pandemic in India.在印度2019冠状病毒病（COVID-19）大流行期间，多种侵袭性真菌感染出现。
Antimicrob Steward Healthc Epidemiol. 2021 Nov 2;1(1):e40. doi: 10.1017/ash.2021.198. eCollection 2021.
3
Does COVID-19 lockdowns have impacted on global dengue burden? A special focus to India.新冠疫情封锁措施对全球登革热负担有影响吗？特别关注印度。
BMC Public Health. 2022 Jul 22;22(1):1402. doi: 10.1186/s12889-022-13720-w.
4
Over the counter drugs and self-medication: A worldwide paranoia and a troublesome situation in India during the COVID-19 pandemic.非处方药与自我药疗：在新冠疫情期间，这是一种全球范围内的偏执观念，在印度也是一个棘手的情况。
Ann Med Surg (Lond). 2022 Jun;78:103797. doi: 10.1016/j.amsu.2022.103797. Epub 2022 May 26.
5
COVID-19 associated pulmonary aspergillosis (CAPA): An added potential burden on India's pre-existing fungal superinfection.2019冠状病毒病相关肺曲霉病（CAPA）：给印度原有的真菌重叠感染增添了潜在负担。
Clin Epidemiol Glob Health. 2022 Jan-Feb;13:100960. doi: 10.1016/j.cegh.2021.100960. Epub 2022 Jan 4.
6
Marburg virus disease outbreak amidst COVID-19 in the Republic of Guinea: A point of contention for the fragile health system?几内亚共和国新冠疫情期间的马尔堡病毒病疫情：这对脆弱的卫生系统来说是一个争议点？
Clin Epidemiol Glob Health. 2022 Jan-Feb;13:100920. doi: 10.1016/j.cegh.2021.100920. Epub 2021 Dec 8.
7
Dual burden of Zika and COVID-19 in India: challenges, opportunities and recommendations.印度寨卡病毒病和2019冠状病毒病的双重负担：挑战、机遇与建议
Trop Med Health. 2021 Oct 18;49(1):83. doi: 10.1186/s41182-021-00378-0.
8
Dengue and Coronavirus disease (COVID-19) syndemic: Double threat to an overburdened healthcare system in Africa.登革热和冠状病毒病（COVID-19）双重流行：对非洲不堪重负的医疗体系的双重威胁。
Int J Health Plann Manage. 2022 May;37(3):1851-1854. doi: 10.1002/hpm.3334. Epub 2021 Sep 14.
9
The risk of cutaneous mucormycosis associated with COVID-19: A perspective from Pakistan.COVID-19 相关皮肤毛霉菌病的风险：来自巴基斯坦的观点。
Int J Health Plann Manage. 2022 Mar;37(2):1157-1159. doi: 10.1002/hpm.3311. Epub 2021 Sep 2.
本文引用的文献
1
COVID-19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India.COVID-19 和毛霉菌病综合征：印度崩溃的医疗体系面临的双重健康威胁。
Trop Med Int Health. 2021 Sep;26(9):1016-1018. doi: 10.1111/tmi.13641. Epub 2021 Jun 24.
2
Colossal challenges to healthcare workers combating the second wave of coronavirus disease 2019 (COVID-19) in India.印度医护人员在抗击2019年冠状病毒病（COVID-19）第二波疫情时面临的巨大挑战。
Infect Control Hosp Epidemiol. 2022 Sep;43(9):1302-1303. doi: 10.1017/ice.2021.257. Epub 2021 Jun 2.
3
Second wave of COVID-19: emergency situation in India.第二波 COVID-19 疫情：印度的紧急状况。
J Travel Med. 2021 Oct 11;28(7). doi: 10.1093/jtm/taab082.
4
Pulmonary Fungal Infections Affect Patients With COVID-19.肺部真菌感染影响新冠肺炎患者。
JAMA. 2020 Dec 8;324(22):2248. doi: 10.1001/jama.2020.22914.
5
Multidrug-Resistant Candida auris Infections in Critically Ill Coronavirus Disease Patients, India, April-July 2020.2020 年 4 月至 7 月，印度新冠肺炎重症患者中出现耐多药念珠菌血症感染。
Emerg Infect Dis. 2020 Nov;26(11):2694-2696. doi: 10.3201/eid2611.203504. Epub 2020 Aug 27.
Zotero 插件